VoxNeuro Announces Research Project with St. Joseph's Healthcare Hamilton

logo-voxneuro.png

VoxNeuro has joined a pilot study led by St. Joseph’s Healthcare Hamilton which is designed to identify biomarkers of bipolar disorder.

The company’s Cognitive Health Assessments ™, a lab-developed tool which provides objective data of a patient’s brain function, will be used alongside blood tests and various behavioural and clinical assessments for bipolar disorder. The objective of the study is to create a bank of potential biomarkers for the different stages of the disease.

Previous
Previous

New investments for Xpan Inc. and Nanology Labs

Next
Next

Aspect Biosystems Announces US$20 Million Series A Financing